{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:45:22Z","timestamp":1770291922333,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T00:00:00Z","timestamp":1728172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cmi.2024.09.027","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T22:19:21Z","timestamp":1728166761000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study"],"prefix":"10.1016","volume":"31","author":[{"given":"Syed Mohammad Mazidur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpita","family":"Samina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanjina","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahammad Shafiq Sikder","family":"Adel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumana","family":"Nasrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Khaja Mafij","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Jahid","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahriar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Daru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pronab Kumar","family":"Modak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Abdul Hamid","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sardar Munim Ibna","family":"Mohsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayera","family":"Banu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.09.027_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021147","article-title":"Tuberculosis drug development: history and evolution of the mechanism-based paradigm","volume":"5","author":"Chakraborty","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cmi.2024.09.027_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003008","article-title":"Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data","volume":"17","author":"Dean","year":"2020","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2024.09.027_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(18)30078-X","article-title":"Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis","volume":"6","author":"Fregonese","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2024.09.027_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.09.027_bib5","series-title":"WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis","year":"2018"},{"key":"10.1016\/j.cmi.2024.09.027_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4046\/trd.2019.0065","article-title":"Treatment of isoniazid-resistant pulmonary tuberculosis","volume":"83","author":"Jhun","year":"2020","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.cmi.2024.09.027_bib7","first-page":"1","year":"2022","journal-title":"Glob Tuberculosis Rep"},{"key":"10.1016\/j.cmi.2024.09.027_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5588\/ijtld.14.0200","article-title":"Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey","volume":"19","author":"Kamal","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2024.09.027_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241437","article-title":"Social enterprise model (SEM) for private sector tuberculosis screening and care in Bangladesh","volume":"15","author":"Banu","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2024.09.027_bib11","first-page":"775","article-title":"Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria","volume":"87","author":"Kubica","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cmi.2024.09.027_bib12","series-title":"Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","year":"2018"},{"key":"10.1016\/j.cmi.2024.09.027_bib13","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.cmi.2024.09.027_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/diagnostics12020410","article-title":"Performance of WHO-endorsed rapid tests for detection of susceptibility to first-line drugs in patients with pulmonary tuberculosis in Bangladesh","volume":"12","author":"Rahman","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cmi.2024.09.027_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmi.2019.10.037","article-title":"Guidance on reporting multivariable regression models in CMI","volume":"26","author":"Leibovici","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.09.027_bib16","first-page":"20","article-title":"First national anti-tuberculosis drug resistance survey (NDRS) from India-an eye opener","volume":"1","author":"Mishra","year":"2018","journal-title":"J\u00a0Infectiol Epidemiol"},{"key":"10.1016\/j.cmi.2024.09.027_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050551","article-title":"High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan","volume":"7","author":"Fasih","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2024.09.027_bib18","unstructured":"National guideline on drug resistant tuberculosis management, Nepal. 2019. https:\/\/nepalntp.gov.np\/wp-content\/uploads\/2019\/10\/DR-TB-Guidelines-2019_Nepal.pdf. [Accessed 21 December 2023]"},{"key":"10.1016\/j.cmi.2024.09.027_bib19","unstructured":"World Health Organization. Tuberculosis profile: Bangladesh. 2023. https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&entity_type=%22country%22&iso2=%22BD%22&lan=%22EN%22. [Accessed 21 March 2024]"},{"key":"10.1016\/j.cmi.2024.09.027_bib21","series-title":"WHO consolidated guidelines on tuberculosis: module 3: diagnosis \u2013 Rapid diagnostics for tuberculosis detection","year":"2024"},{"key":"10.1016\/j.cmi.2024.09.027_bib22","series-title":"Use of targeted next-generation sequencing to detect drug-resistant tuberculosis: rapid communication, July 2023","year":"2023"},{"key":"10.1016\/j.cmi.2024.09.027_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2024.09.027_bib24","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S2468-2667(19)30130-6","article-title":"Precision medicine and public health interventions: tuberculosis as a model?","volume":"4","author":"Temesgen","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.cmi.2024.09.027_bib25","author":"Bidarbakht-Nia"},{"key":"10.1016\/j.cmi.2024.09.027_bib26","unstructured":"National Tuberculosis Control Programme (NTP) Bangladesh. Annual report. 2022. https:\/\/www.ntp.gov.bd\/wp-content\/uploads\/2024\/01\/Annual-Report-2022.pdf. [Accessed 16 August 2024]"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:53:19Z","timestamp":1738450399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1198743X24004749"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.09.027","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}